News About: Pharm. Industry
Korea, China seek to expand mutual business cooperation
Executives from the Korea Pharmaceutical Manufacturers Association (KPMA) and the Chinese Pharmaceutical Industry Association agreed to work together to form a new business collaboration, such as the hosting of inform...
Korea’s drug sales index fall in July
Korea’s drug sales index posting 97.0 showed a slide of 1.3 percent in July from a year earlier, an institutional investor said Monday.
According to Shinhan Investment, the domestic drug shipment index rose 4.9 per...
Drug makers increase cashable assets amid economic woes and unpredictable variables
Influenced by persistent market uncertainty together with worsening business conditions, Korean pharmaceutical firms are choosing to hold more of their earnings in cashable assets as they find it harder to invest.
...
Celltrion’s Remsia in spotlight
Celltrion’s biosimilar monoclonal antibody Remsima (infliximab) is currently under the industry spotlight after the company gained market authorization from the European Commission on August 28.
The clinical report...
Pharmaceutical market polarization deepens
Despite their relatively large assets, the nation’s 54 Korean pharmaceutical companies spend considerably less on research and development (R&D) than promotional expenses, industry data showed recently.
According ...
Daewoong gets US prequalification approval for carbapenem antibiotic
A Korean antibiotic drug has won prequalification approval from the Food and Drug Administration of the United States for sale in the country, the company said Monday, a move that will give the local drugmaker access ...
Listed drugmakers see marketing expenses fall in H1
Korean drug manufacturers saw a contraction in their marketing outlays in the first half on a year-on-year basis, apparently hit by weaker bottom line due to the government-mandated cuts in drug prices last year.
A...
Korean drug makers in sales quagmire
Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products. But those measures have not been enough to stop a fall in...
Pharmacists to protest against plan to re-categorize some in vitro tests
The Korean Pharmaceutical Association (KPA) has vowed to protest the government's plan to "re-categorize" some of in vitro diagnostic testers as part of measures to reduce customers' inconvenience in buying such medic...
CJ Venture Investment lends help to new businesses
CJ Venture Investment will step up efforts to support local bioventure start-ups by taking a lead role in a shared growth initiative.
CJ announced on Thursday that it signed a Memorandum of Understanding (MOU) with...
